Globus Medical Inc (NYSE: GMED). Extremely significant positive changes in investment behavior have recently occurred: the stock rose on very heavy volume, and positive upside/downside volume developed.
Significant positive changes in Globus Medical Inc (NYSE: GMED) fundamentals have recently occurred: significant quarterly earnings acceleration occurred, and the consensus estimate for December, 2024 increased significantly.
In light of these very positive signals we are reviewing our current Overall Rating of A. We would continue to view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
Globus Medical has a current Value Trend Rating of A (Highest Rating). This rating combines complementary signals from two proprietary PTR measures of a stock’s attractiveness. Globus Medical has a slightly positive Appreciation Score of 66 and a very high Power Rating of 90, leading to the Highest Value Trend Rating.
Recent Price Action
Globus Medical Inc (NYSE: GMED) stock closed at $84.91 on 11/21/24 after an increase of 1.6%. Moreover, exceptionally high trading volume at 202% of normal accompanied the advance. The stock has risen 2.9% during the last week and has been exceptionally strong relative to the market over the last nine months.
Be the first to comment